197 related articles for article (PubMed ID: 31521611)
1. Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.
Huang C; Wu S; Li W; Herkilini A; Miyagishi M; Zhao H; Kasim V
EBioMedicine; 2019 Oct; 48():248-263. PubMed ID: 31521611
[TBL] [Abstract][Full Text] [Related]
2. p52-ZER6: a determinant of tumor cell sensitivity to MDM2-p53 binding inhibitors.
Li WF; Alfason L; Huang C; Tang Y; Qiu L; Miyagishi M; Wu SR; Kasim V
Acta Pharmacol Sin; 2023 Mar; 44(3):647-660. PubMed ID: 35995868
[TBL] [Abstract][Full Text] [Related]
3. A novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alpha.
Conroy AT; Sharma M; Holtz AE; Wu C; Sun Z; Weigel RJ
J Biol Chem; 2002 Mar; 277(11):9326-34. PubMed ID: 11779858
[TBL] [Abstract][Full Text] [Related]
4. p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.
Li W; Huang C; Qiu L; Tang Y; Zhang X; Zhang L; Zhao H; Miyagishi M; Kasim V; Wu S
Oncogene; 2024 May; ():. PubMed ID: 38773262
[TBL] [Abstract][Full Text] [Related]
5. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
6. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
[TBL] [Abstract][Full Text] [Related]
7. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.
Huang C; Wu S; Ji H; Yan X; Xie Y; Murai S; Zhao H; Miyagishi M; Kasim V
Sci Adv; 2017 Oct; 3(10):e1701383. PubMed ID: 29057323
[TBL] [Abstract][Full Text] [Related]
8. The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway.
Tang Y; Li W; Qiu L; Zhang X; Zhang L; Miyagishi M; Zhao H; Wu S; Kasim V
Oncogenesis; 2023 Mar; 12(1):17. PubMed ID: 36977688
[TBL] [Abstract][Full Text] [Related]
9. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
10. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
11. p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth.
Zhao Z; Wu L; Shi H; Wu C
Mol Med Rep; 2014 May; 9(5):1903-8. PubMed ID: 24584189
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
Schumm K; Rocha S; Caamano J; Perkins ND
EMBO J; 2006 Oct; 25(20):4820-32. PubMed ID: 16990795
[TBL] [Abstract][Full Text] [Related]
14. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
[TBL] [Abstract][Full Text] [Related]
15. The contribution of the RING finger domain of MDM2 to cell cycle progression.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
[TBL] [Abstract][Full Text] [Related]
16. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
Marques YM; de Lima Mde D; de Melo Alves Sde M; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
Oral Oncol; 2008 Sep; 44(9):903-8. PubMed ID: 18485798
[TBL] [Abstract][Full Text] [Related]
17. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
Gu J; Wang B; Liu Y; Zhong L; Tang Y; Guo H; Jiang T; Wang L; Li Y; Cai L
Eur J Cancer; 2014 Apr; 50(6):1184-94. PubMed ID: 24447832
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
Giono LE; Manfredi JJ
Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
[TBL] [Abstract][Full Text] [Related]
20. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
